@article{23892,
  author = {Anderson Craig and Lavados P and Olavarría V and Bashir S and Kasner S and Barroso C and Ahmad N and Swaminathan B and Sharma M and Muir K and Veltkamp R and Ameriso S and Ameriso S and Endres M and Lutsep H and Messé S and Spence J and Nedeltechev K and Perera K and Santo G and Lindgren A and Bangdiwala S and Shoamanesh A and Berkowitz S and Mundl H and Connolly S and Hart R and Abdelhamid N and Abdul R and Abdul-Saheb M and Abreu P and Abroskina M and Abu A and Accassat S and Acciaresi M and Adami A and Ahmed F and Alberto H and Alemseged F and Ali A and Altavilla R and Alwis L and Amarenco P and Amaro S and Amaya S and Amelia P and Amin H and Amino T and Amjad A and Anagnostou E and Andersen G and Anderson D and Andrea F and Andres M and Andreu D and Androulakis M and Angel G and Angel S and Angeles D and Angels F and Anticoli S and Arauz A and Arauz G and Araya P and Arenillas L and Arias R and Arnold M and Augustin S and Avelar W and Azevedo E and Babikian V and Bacellar A and Badalyan K and Bae H and Baez M and Bagelmann H and Bailey P and Bak Z and Baker M and Balazs A and Baldaranov D and Balogun I and Balueva T and Bankuti Z and Bar M and Baranowska A and Bardutzky J and Barker T and Barlinn J and Baronnet F and Barteys M and Bartolottiova T and Barulin A and Bas M and Basile V and Bathe-Peters R and Bathula R and Batista C and Batur C and Baumgartner P},
  title = {Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial},
  year = {2018},
  journal = {The Lancet Neurology},
  volume = {17},
  pages = {1053 - 1060},
  month = {-31150635653},
  doi = {10.1016/S1474-4422(18)30319-3},
  language = {eng},
}